CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,898,837
- in 74 filings, $342.1M under 10b5-1 plans
Net −$342,898,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-15 | ROTHBLATT MARTINE A Chairperson & CEO | Shares withheld for taxes | −13,637 | $536.12 | $7.3M | 56,072 |
| 2026-03-15 | ROTHBLATT MARTINE A Chairperson & CEO | Shares withheld for taxes | −15,559 | $536.12 | $8.3M | 40,513 |
| 2026-03-15 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Restricted Stock Units | −32,499 | 0 | ||
| 2026-03-15 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Restricted Stock Units | −37,080 | 0 | ||
| 2026-03-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −75 | $536.95 | $40K | 324,443 |
| 2026-03-13 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 9,630 |
| 2026-03-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −944 | $535.43 | $505K | 8,686 |
| 2026-03-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,536 | $536.32 | $824K | 7,150 |
| 2026-03-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,030 | $537.29 | $1.1M | 5,120 |
| 2026-03-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,019 | $538.31 | $1.1M | 3,101 |
| 2026-03-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,546 | $539.26 | $834K | 1,555 |
| 2026-03-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −865 | $540.27 | $467K | 690 |
| 2026-03-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −480 | $541.21 | $260K | 210 |
| 2026-03-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $542.04 | $43K | 130 |
| 2026-03-13 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 145,000 | ||
| 2026-03-12 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 9,630 |
| 2026-03-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −640 | $532.16 | $341K | 8,990 |
| 2026-03-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −60 | $532.97 | $32K | 8,930 |
| 2026-03-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,955 | $536.02 | $1.0M | 6,459 |
| 2026-03-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,772 | $536.83 | $951K | 4,687 |
Page 148 of 171 · 3,408 trades